Second-line therapy for severe pediatric ulcerative colitis

被引：0
|
作者：
Susan R. Orenstein
机构：
来源：
Current Gastroenterology Reports | 2009年 / 11卷 / 3期
关键词：
Ulcerative Colitis; Ulcerative Colitis Patient; Toxic Megacolon; Intravenous Steroid; Steroid Dependency;
D O I：
10.1007/s11894-009-0026-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 169
页数：2
相关论文
共 50 条
  • [31] Axitinim believe in Second-Line Therapy
    Roos, Frederik
    AKTUELLE UROLOGIE, 2012, 43 (03) : 135 - 137
  • [32] Second-line therapy for esophageal cancer
    Martin, Mike G.
    Govindan, Ramoswamy
    Morgensztern, Daniel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 871 - 876
  • [33] Vedolizumab is superior to anti-tumor necrosis factor agents as a first-line biological agent but not as a second-line biological agent in moderate to severe ulcerative colitis
    Pudipeddi, A.
    Ko, Y.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 136 - 136
  • [34] VEDOLIZUMAB IS SUPERIOR TO ANTI-TUMOR NECROSIS FACTOR AGENTS AS A FIRST-LINE BIOLOGICAL AGENT BUT NOT AS A SECOND-LINE BIOLOGICAL AGENT IN MODERATE TO SEVERE ULCERATIVE COLITIS
    Pudipeddi, Aviv
    Ko, Yanna
    Paramsothy, Sudarshan
    Leong, Rupert W.
    GASTROENTEROLOGY, 2021, 160 (06) : S343 - S343
  • [35] Dolutegravir for second-line antiretroviral therapy
    Hamers, Raph L.
    LANCET INFECTIOUS DISEASES, 2019, 19 (03): : 218 - 219
  • [36] Second-line therapy in colorectal cancer
    Berlin, J
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 21 - 26
  • [37] Second-line therapy of ovarian carcinoma
    Sevelda, P
    ONKOLOGIE, 2000, 23 (06): : 593 - 596
  • [38] Second-line drug therapy for osteoarthritis
    Brandt, KD
    CLINICAL MEDICINE, 2001, 1 (02) : 110 - 112
  • [39] Second-Line Therapy for Advanced NSCLC
    Weiss, Jared M.
    Stinchcombe, Thomas E.
    ONCOLOGIST, 2013, 18 (08): : 947 - 953
  • [40] Second-line therapy in bladder cancer
    Bachner, Mark
    De Santis, Maria
    CURRENT OPINION IN UROLOGY, 2009, 19 (05) : 533 - 539
12345